Skip to main content
All lobbying filings

FRESENIUS KABI USA LLC

Lobbying for FRESENIUS KABI USA LLC

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $320,000.00 expenses · posted Oct 17, 2025

Official filing document

 Bills named in this filing 14
 Lobbying activity 6
Budget/Appropriations

Domestic Manufacturing Tariffs

Copyright/Patent/Trademark

PTAB Discretionary Denials

Trade (domestic/foreign)

Drug Shortages Domestic Manufacturing Tariffs

Medicare/Medicaid

Drug Shortages and Medicaid ERISA Fiduciary Duty IRA Reform

Manufacturing

Domestic Manufacturing

Health Issues

S. 1954/H.R. 5526: Biosimilar Red Tape Elimination Act S. 1414/H.R._: Expedited Access to Biosimilars Act S. 2276/H.R. 3269: Eliminating Thickets to Increase Competition (ETHIC) Act S. 1041: Affordable Prescriptions for Patients Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 43: Skinny Labels, Big Savings Act S. 1097/H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 HR 4317: PBM Reform Act of 2025 HR 2214: DRUG Act S. 1553/H.R. 3160: PREVAIL Act ERISA Fiduciary Duty PTAB Discretionary Denials IRA Reform Human Factor Studies Interchangeability Biosimilar User Fee Act (BsUFA) Drug Shortages Domestic Manufacturing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem